An initial reading of third-quarter gross domestic product showed the US economy expanded at an inflation-adjusted annualized rate of 4.3%, a far faster pace than the 3.8% recorded in the second ...

Mike Newton is on his way to early retirement, thanks to his 26-unit real estate portfolio. Newton has financed properties with traditional 30-year mortgages and seller financing. He's recently been ...

Concerns over competitors using AI pricing tools to fix prices have dominated antitrust discussions in the U.S. and EU. Recent cases show how algorithmic pricing might enable unlawful coordination.

This past summer, a fire at an electrical substation forced data centers in Loudoun County to rely on backup diesel generators as their power source. Grid failures like this happen often, but this ...

Johnson & Johnson JNJ announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate dual-action tablet), for a second indication in prostate cancer. The agency has ...

With Android QPR2, which started rolling out a few days ago in early December, Google is bringing a slew of cool new features to Android — specifically its Pixel phones. One of these is a feature I’m ...

A judge dismissed indictments against two of the president’s foes, but a new Pentagon investigation of a prominent Democrat shows how he is using a whole-of-government approach to punish those who ...

To better understand which social media platforms Americans use, Pew Research Center surveyed 5,022 U.S. adults from Feb. 5 to June 18, 2025. SSRS conducted this National Public Opinion Reference ...

Following a report earlier this week, Anthropic (ANTHRO) confirmed on Thursday that it has widened the scope of its deal with Google (NASDAQ:GOOG) (NASDAQ:GOOGL). The newly expanded deal will see ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted expanded use of von Willebrand factor for adults and certain children with von Willebrand ...

On Thursday, the U.S. Food and Drug Administration (FDA) extended the Prescription Drug User Fee Act (PDUFA) goal date for Agios Pharmaceuticals, Inc.’s (NASDAQ:AGIO) supplemental New Drug Application ...